A multicenter phase II randomized study of customized neoadjuvant therapy versus standard chemotherapy (CT) in non-small cell lung cancer (NSCLC) patients with resectable stage IIIA(N2) disease (CONTEST trial).
Francesco Grossi
No relevant relationships to disclose
Erika Rijavec
No relevant relationships to disclose
Giulia Barletta
No relevant relationships to disclose
Claudio Sini
No relevant relationships to disclose
Carlo Genova
No relevant relationships to disclose
Maria Giovanna Dal Bello
No relevant relationships to disclose
Giovanni Battista Ratto
No relevant relationships to disclose
Mauro Truini
No relevant relationships to disclose
Domenico Franco Merlo
No relevant relationships to disclose